XETRA - Delayed Quote EUR

BRAIN Biotech AG (BNN.DE)

Compare
3.5500 +0.1000 (+2.90%)
At close: 2:06:16 PM GMT+1

Key Executives

Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
NameTitlePayExercisedYear Born
Mr. Adriaan Moelker Chairman of the Management Board & CEO 620k -- --
Mr. Ulrich Putsch Co-Founder -- -- --
Mr. Michael Schneiders CFO & Member of Management Board -- -- 1970
Dr. Ute Dechert Vice President of Human Resources & Processes -- -- 1961
Dr. Jurgen Eck Consultant 392k -- 1962
Dr. Martin Langer MD & Executive VP -- -- 1965
Dr. Alexander Pelzer VP and Head of Research & Development - Zwingenberg -- -- 1986
Mr. Robbert Michael Hoekstra Head of Group Finance -- -- 1978
Mr. Paul Scholz Technical Lead of Genome Editing Development -- -- --

BRAIN Biotech AG

DarmstAedter Strasse 34-36
Zwingenberg, 64673
Germany
49 62 51 9331 0 https://www.brain-biotech.com
Full Time Employees: 
319

Description

BRAIN Biotech AG engages in the research and development of Bio-based products and solutions in Germany, the United States, France, the Netherlands, and the United Kingdom. It operates in three segments: BioProducts, BioScience, and BioIncubator. The company offers enzymes and biocatalysts to produce food and beverages, wound care preparations or lubricants, and production of starch and bioethanol; and microorganisms as the functional biomass for optimized industrial production processes, recycling of the greenhouse gas CO2 as an industrial raw material, and urban and green mining for extraction of precious and rare earth metals. It also provides biocatalysts and other bioactive natural compounds to produce foodstuffs and animal feed, cosmetics, and medical products, as well as for industrial applications in chemical companies, waste and hazardous materials disposal, and energy and raw materials production. The company was formerly known as B.R.A.I.N. Biotechnology Research and Information Network AG and changed its name to BRAIN Biotech AG in April 2021. BRAIN Biotech AG was founded in 1993 and is headquartered in Zwingenberg, Germany.

Corporate Governance

BRAIN Biotech AG’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

January 15, 2025 at 10:59 AM UTC

BRAIN Biotech AG Earnings Date

Recent Events

Related Tickers